1. Home
  2. IMAB vs VGI Comparison

IMAB vs VGI Comparison

Compare IMAB & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • VGI
  • Stock Information
  • Founded
  • IMAB 2014
  • VGI 2012
  • Country
  • IMAB United States
  • VGI United States
  • Employees
  • IMAB N/A
  • VGI N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • VGI Investment Managers
  • Sector
  • IMAB Health Care
  • VGI Finance
  • Exchange
  • IMAB Nasdaq
  • VGI Nasdaq
  • Market Cap
  • IMAB 79.9M
  • VGI 89.5M
  • IPO Year
  • IMAB 2020
  • VGI N/A
  • Fundamental
  • Price
  • IMAB $0.96
  • VGI $7.80
  • Analyst Decision
  • IMAB Strong Buy
  • VGI
  • Analyst Count
  • IMAB 3
  • VGI 0
  • Target Price
  • IMAB $8.00
  • VGI N/A
  • AVG Volume (30 Days)
  • IMAB 286.0K
  • VGI 46.0K
  • Earning Date
  • IMAB 03-13-2025
  • VGI 01-01-0001
  • Dividend Yield
  • IMAB N/A
  • VGI 12.66%
  • EPS Growth
  • IMAB N/A
  • VGI N/A
  • EPS
  • IMAB N/A
  • VGI N/A
  • Revenue
  • IMAB $569,464.00
  • VGI N/A
  • Revenue This Year
  • IMAB N/A
  • VGI N/A
  • Revenue Next Year
  • IMAB N/A
  • VGI N/A
  • P/E Ratio
  • IMAB N/A
  • VGI N/A
  • Revenue Growth
  • IMAB N/A
  • VGI N/A
  • 52 Week Low
  • IMAB $0.84
  • VGI $6.68
  • 52 Week High
  • IMAB $2.00
  • VGI $7.99
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • VGI 50.91
  • Support Level
  • IMAB $0.95
  • VGI $7.70
  • Resistance Level
  • IMAB $1.04
  • VGI $7.94
  • Average True Range (ATR)
  • IMAB 0.06
  • VGI 0.07
  • MACD
  • IMAB -0.01
  • VGI 0.00
  • Stochastic Oscillator
  • IMAB 19.88
  • VGI 53.13

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.

Share on Social Networks: